[Federal Register Volume 64, Number 137 (Monday, July 19, 1999)]
[Notices]
[Pages 38689-38690]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-18335]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-828 (Preliminary)]
Bulk Acetylsalicylic Acid (Aspirin) From China
Determination
On the basis of the record 1 developed in the subject
investigation, the United States International Trade Commission
determines, pursuant to section 733(a) of the Tariff Act of 1930 (19
U.S.C. 1673b(a)), that there is a reasonable indication that an
industry in the United States is threatened with material injury by
reason of imports from China of bulk acetylsalicylic acid (aspirin),
provided for in subheadings 2918.22.10 and 3003.90.00 of the Harmonized
Tariff Schedule of the United States, that are alleged to be sold in
the United States at less than fair value (LTFV). 2
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
rules of practice and procedure (19 CFR 207.2(f)).
\2\ Commissioner Carol T. Crawford determines that there is a
reasonable indication that an industry in the United States is
materially injured by reason of the subject imports from China that
are alleged to be sold in the United States at LTFV.
---------------------------------------------------------------------------
Commencement of Final Phase Investigation
Pursuant to section 207.18 of the Commission's rules, the
Commission also gives notice of the commencement of the final phase of
its investigation. The Commission will issue a final phase notice of
scheduling which will be published in the Federal Register as provided
in Sec. 207.21 of the Commission's rules upon notice from the
Department of Commerce (Commerce) of an affirmative preliminary
determination in the investigation under section 733(b) of the Act, or,
if the preliminary determination is negative, upon notice of an
affirmative final determination in that investigation under section
735(a) of the Act. Parties that filed entries of appearance in the
preliminary phase of the investigation need not enter a separate
appearance for the final phase of the investigation. Industrial users,
and, if the merchandise under investigation is sold at the retail
level, representative consumer organizations have the right to appear
as parties in Commission antidumping and countervailing duty
investigations. The Secretary will prepare a public service list
containing the names and addresses of all persons, or their
representatives, who are parties to the investigation.
[[Page 38690]]
Background
On May 28, 1999, a petition was filed with the Commission and the
Department of Commerce by Rhodia, Inc., Cranbury, NJ, alleging that an
industry in the United States is materially injured or threatened with
material injury by reason of LTFV imports of bulk aspirin from China.
Accordingly, effective May 28, 1999, the Commission instituted
antidumping investigation No. 731-TA-828 (Preliminary).
Notice of the institution of the Commission's investigation and of
a public conference to be held in connection therewith was given by
posting copies of the notice in the Office of the Secretary, U.S.
International Trade Commission, Washington, DC, and by publishing the
notice in the Federal Register of June 7, 1999 (64 FR 30355). The
conference was held in Washington, DC, on June 18, 1999, and all
persons who requested the opportunity were permitted to appear in
person or by counsel.
The Commission transmitted its determination in this investigation
to the Secretary of Commerce on July 12, 1999. The views of the
Commission are contained in USITC Publication 3211 (July 1999),
entitled Bulk Acetylsalicylic Acid (Aspirin) from China: Investigation
No. 731-TA-828 (Preliminary).
By order of the Commission.
Issued: July 13, 1999.
Donna R. Koehnke,
Secretary.
[FR Doc. 99-18335 Filed 7-16-99; 8:45 am]
BILLING CODE 7020-02-P
